Midtrimester preterm prelabour rupture of membranes (PPROM): Expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)
Augustinus S.P. van Teeffelen*, David P. van der Ham, Christine Willekes, Salwan Al Nasiry, Jan G. Nijhuis, Sander van Kuijk, Ewoud Schuyt, Twan L.M. Mulder, Maureen T.M. Franssen, Dick Oepkes, Fenna A.R. Jansen, Mallory D. Woiski, Mireille N. Bekker, Caroline J. Bax, Martina M. Porath, Monique W.M. de Laat, Ben W. Mol, Eva Pajkrt
Dive into the research topics of 'Midtrimester preterm prelabour rupture of membranes (PPROM): Expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial)'. Together they form a unique fingerprint.